Phreesia Reports 10% Revenue Growth to $129.5 Million in Q2 Fiscal 2027

Phreesia, Inc. reported a notable increase in financial performance for the second quarter of fiscal 2027, with total revenue rising 10% to $129.5 million compared to $117.3 million in the same period last year. For the six months ending July 31, 2026, revenue increased by 12% to $260.4 million, up from $233.2 million in the prior year. The company achieved net income of $1.9 million for the quarter, a significant improvement from the $0.7 million reported in the same quarter of the previous year. Over the six-month period, net income reached $4.9 million, contrasting with a net loss of $3.3 million in the prior year.

The company's financial results reflect strategic developments, including the acquisition of AccessOne, which contributed to the growth in payment solutions revenue, which surged 36% to $38.5 million for the quarter and 38% to $80.4 million for the six months. Subscription and related services revenue, however, saw a slight decline of 2% for both the quarter and the half-year, attributed to one-time adjustments and a decrease in non-recurring fees. Network solutions revenue also increased, driven by enhanced engagement and education programs.

Operationally, Phreesia reported an increase in its average number of healthcare services clients (AHSCs) to 4,744 for the quarter, up from 4,467 a year earlier. This growth in client count is a key indicator of the company's performance and is expected to drive future revenue growth. The company also reported a total revenue per AHSC of $27,289, reflecting a 4% increase year-over-year, primarily due to growth in network solutions revenue. As of July 31, 2026, Phreesia had cash, cash equivalents, and restricted cash totaling $74.6 million, a slight increase from $73.8 million at the beginning of the fiscal year.

Phreesia's restructuring plan, initiated in May 2026, aims to reduce operating expenses by eliminating approximately 220 positions, with expected charges of around $10 million. The company anticipates that this restructuring will yield significant cost savings in the long term. Additionally, the company is navigating a complex macroeconomic environment, including geopolitical uncertainties and inflationary pressures, which could impact future performance. Despite these challenges, management believes that existing cash reserves and operational cash flow will be sufficient to meet liquidity needs for at least the next 12 months.

Looking ahead, Phreesia remains focused on integrating AccessOne's operations and enhancing its product offerings, particularly in artificial intelligence and patient engagement solutions. The company is also monitoring market conditions closely to adapt its strategies accordingly. The ongoing integration of AccessOne is expected to provide additional revenue-generating opportunities, further solidifying Phreesia's position in the healthcare technology sector.